Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”
Saved in:
Main Authors: | Xiao-Wen Chen, Xiao-Yan Du, Yu-Xian Wang, Jian-Cheng Wang, Wen-Ting Liu, Wen-Jing Chen, Hong-Yu Li, Fen-Fen Peng, Zhao-Zhong Xu, Hong-Xin Niu, Hai-Bo Long |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2016/3151986 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in db/db Mice Using Cytokine Antibody Array
by: Xue Mei Fan, et al.
Published: (2018-01-01) -
α-methyltryptophan-mediated protection against diabetic nephropathy in db/db mice as studied with a metabolomics approach
by: Aimin Cai, et al.
Published: (2025-01-01) -
Pyruvate-Enriched Oral Rehydration Solution Improves Glucometabolic Disorders in the Kidneys of Diabetic db/db Mice
by: Xiao Meng Zhang, et al.
Published: (2020-01-01) -
Investigation of the Protective Effects of Phlorizin on Diabetic Cardiomyopathy in db/db Mice by Quantitative Proteomics
by: Qian Cai, et al.
Published: (2013-01-01) -
Gut Microbiota Composition and Structure of the Ob/Ob and Db/Db Mice
by: Mingsheng Yang, et al.
Published: (2019-01-01)